Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rates are ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Medically reviewed by Soma Mandal, MD Petechiae are tiny red, purple, or brown spots on your skin, inside of your mouth, or ...

Patients on oral anticoagulants or antiplatelet agents showed no meaningful difference in detection rates. Oral anticoagulant or antiplatelet medication use had no substantial effect on the ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Exposure to traffic-related air pollution (TRAP) is associated with depression in women, possibly via reproductive health, according to a study published ...

For people with acute coronary syndrome, the current standard of care involves a combination of aspirin and a P2Y12 inhibitor (known as dual antiplatelet therapy or DAPT) for a period of time ...

Kyprolis can interact with anticoagulants and antiplatelets, which are prescribed to treat and help prevent blood clots. Kyprolis, as well as antiplatelets and anticoagulants, increases your risk ...